ArticleEndocrine, metabolic & immune disorders drug targets2026
Semaglutide and Musculoskeletal Health: A Mendelian Randomization Study Based on GLP-1 Receptor Expression.
Dong Li et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.